NEW YORK (GenomeWeb News) – Agilent Technologies reported after the close of the market on Wednesday that revenues during its fiscal third quarter inched up 2 percent year over year as the company missed the average analyst estimate on the top and bottom line.

For the three months ended July 31, revenues totaled $1.72 billion, compared to $1.69 billion for the third quarter a year ago. The company fell short of the average analyst estimate of $1.79 billion.

Orders during the quarter were down 2 percent to $1.66 billion from $1.69 billion a year ago.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.